Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1998 May;152(5):1209–1223.

Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat.

L C Paul 1, J Muralidharan 1, S A Muzaffar 1, E H Manting 1, J F Valentin 1, E de Heer 1, M Kashgarian 1
PMCID: PMC1858589  PMID: 9588890

Abstract

Antibodies or cell-mediated immunity can cause chronic rejection of vascularized organ grafts, but the nature and specificity of the antigen(s) involved has remained elusive. We have previously demonstrated the presence of antibodies against cryptic glomerular basement membrane antigens and undefined antigens in the mesangial area in rats with chronic renal allograft rejection. Current experiments were designed to study the post-transplant antibody response against cultured mesangial and endothelial cells in rats with chronic rejection using flow cytometry, indirect immunofluorescent staining, immunoelectron microscopy, confocal microscopy, and Western blots. The results were compared with those obtained with alloantisera raised by immunization with cultured mesangial cells. Post-transplant and post-immunization sera contained IgG antibodies against trypsinized mesangial cells detected by flow cytometry. Indirect immunofluorescent studies using mesangial cells grown on coverslips showed autoantibody binding to cytoplasmic granules in cultures early after plating whereas staining of later cultures showed antibody binding in an interrupted, web-like pattern on the outside of the cells. Immunoelectron microscopy showed autoantibody binding to intracellular secretory granules and to cell surface focal adhesion plaques. The latter finding was confirmed in double-labeling experiments with an antiserum against vinculin. Western blots with mesangial cell culture supernatants demonstrated autoantibody reactivity with antigens in the 40-kd and 60- to 70-kd range, and immunoprecipitation identified these molecules as biglycan and decorin. Absorption of the sera with mesangial cell culture supernatant removed most of the antibodies except those that gave a punctate staining with the mesangial cell surface. However, not all immunostaining of mesangial cells could be explained by antibodies against biglycan and decorin. Post-transplant sera, furthermore, contained low-titered antibodies against endothelial cells. We conclude that rats with chronic renal transplant rejection produce a strong autoantibody response against mesangial cell focal adhesion plaques and proteins secreted by these cells in culture. Such antibodies may cause local damage and interfere in the tissue repair process after injury.

Full text

PDF
1213

Images in this article

1214Figure 2
on p.1214
1215Figure 4
on p.1215
1216Figure 5
on p.1216
1216Figure 6
on p.1216
1216Figure 7
on p.1216
1217Figure 8
on p.1217
1217Figure 9
on p.1217
1217Figure 10
on p.1217
1218Figure 12
on p.1218
1219Figure 13
on p.1219
1219Figure 14
on p.1219

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S., Baker P. J., Johnson R. J., Ochi R. F., Pritzl P., Couser W. G. Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest. 1986 Mar;77(3):762–767. doi: 10.1172/JCI112372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bagchus W. M., Hoedemaeker P. J., Rozing J., Bakker W. W. Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. Lab Invest. 1986 Dec;55(6):680–687. [PubMed] [Google Scholar]
  3. Benediktsson H., Chea R., Davidoff A., Paul L. C. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function. Transplantation. 1996 Dec 15;62(11):1634–1642. doi: 10.1097/00007890-199612150-00018. [DOI] [PubMed] [Google Scholar]
  4. Bidanset D. J., LeBaron R., Rosenberg L., Murphy-Ullrich J. E., Hook M. Regulation of cell substrate adhesion: effects of small galactosaminoglycan-containing proteoglycans. J Cell Biol. 1992 Sep;118(6):1523–1531. doi: 10.1083/jcb.118.6.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Border W. A., Noble N. A. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994 Nov 10;331(19):1286–1292. doi: 10.1056/NEJM199411103311907. [DOI] [PubMed] [Google Scholar]
  6. Border W. A., Noble N. A., Yamamoto T., Harper J. R., Yamaguchi Y. u., Pierschbacher M. D., Ruoslahti E. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature. 1992 Nov 26;360(6402):361–364. doi: 10.1038/360361a0. [DOI] [PubMed] [Google Scholar]
  7. Brennan D. C., Jevnikar A. M., Takei F., Reubin-Kelley V. E. Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1. Kidney Int. 1990 Dec;38(6):1039–1046. doi: 10.1038/ki.1990.310. [DOI] [PubMed] [Google Scholar]
  8. Brenner B. M., Meyer T. W., Hostetter T. H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9;307(11):652–659. doi: 10.1056/NEJM198209093071104. [DOI] [PubMed] [Google Scholar]
  9. Buchler M., al Najjar A., Guerraoui A., Valentin J. F., Boulanger M. D., Sherobeen R., Lataste A., Nivet H., Lebranchu Y. Posttransplant anti-HLA antibodies: risk factor for chronic rejection? Transplant Proc. 1995 Aug;27(4):2478–2479. [PubMed] [Google Scholar]
  10. Costa A. N., Scolari M. P., Iannelli S., Buscaroli A., D'Arcangelo G. L., Brando B., Indiveri F., Savi M., Borgnino L. C., DeSanctis L. B. The presence of posttransplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies. Transplantation. 1997 Jan 15;63(1):167–169. doi: 10.1097/00007890-199701150-00033. [DOI] [PubMed] [Google Scholar]
  11. Crisp S. J., Dunn M. J., Rose M. L., Barbir M., Yacoub M. H. Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease? J Heart Lung Transplant. 1994 Jan-Feb;13(1 Pt 1):81–92. [PubMed] [Google Scholar]
  12. Fisher L. W., Termine J. D., Young M. F. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem. 1989 Mar 15;264(8):4571–4576. [PubMed] [Google Scholar]
  13. Fukushima D., Bützow R., Hildebrand A., Ruoslahti E. Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans. J Biol Chem. 1993 Oct 25;268(30):22710–22715. [PubMed] [Google Scholar]
  14. HAMBURGER J., CROSNIER J., DORMONT J. OBSERVATIONS IN PATIENTS WITH A WELL-TOLERATED HOMOTRANSPLANTED KIDNEY: POSSIBILITY OF A NEW SECONDARY DISEASE. Ann N Y Acad Sci. 1964 Nov 30;120:558–577. doi: 10.1111/j.1749-6632.1964.tb34753.x. [DOI] [PubMed] [Google Scholar]
  15. Habib R., Zurowska A., Hinglais N., Gubler M. C., Antignac C., Niaudet P., Broyer M., Gagnadoux M. F. A specific glomerular lesion of the graft: allograft glomerulopathy. Kidney Int Suppl. 1993 Jul;42:S104–S111. [PubMed] [Google Scholar]
  16. Haneda M., Kikkawa R., Koya D., Shikano T., Sugimoto T., Togawa M., Shigeta Y. Endothelin-1 stimulates tyrosine phosphorylation of p125 focal adhesion kinase in mesangial cells. J Am Soc Nephrol. 1995 Nov;6(5):1504–1510. doi: 10.1681/ASN.V651504. [DOI] [PubMed] [Google Scholar]
  17. Harper P. A., Robinson J. M., Hoover R. L., Wright T. C., Karnovsky M. J. Improved methods for culturing rat glomerular cells. Kidney Int. 1984 Dec;26(6):875–880. doi: 10.1038/ki.1984.231. [DOI] [PubMed] [Google Scholar]
  18. Hohage H., Kleyer U., Brückner D., August C., Zidek W., Spieker C. Influence of proteinuria on long-term transplant survival in kidney transplant recipients. Nephron. 1997;75(2):160–165. doi: 10.1159/000189525. [DOI] [PubMed] [Google Scholar]
  19. Hohage H., Kleyer U., Brückner D., August C., Zidek W., Spieker C. Influence of proteinuria on long-term transplant survival in kidney transplant recipients. Nephron. 1997;75(2):160–165. doi: 10.1159/000189525. [DOI] [PubMed] [Google Scholar]
  20. Hosenpud J. D., Everett J. P., Morris T. E., Mauck K. A., Shipley G. D., Wagner C. R. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation. 1995 Jul 15;92(2):205–211. doi: 10.1161/01.cir.92.2.205. [DOI] [PubMed] [Google Scholar]
  21. Hosenpud J. D., Mauck K. A., Hogan K. B. Cardiac allograft vasculopathy: IgM antibody responses to donor-specific vascular endothelium. Transplantation. 1997 Jun 15;63(11):1602–1606. doi: 10.1097/00007890-199706150-00011. [DOI] [PubMed] [Google Scholar]
  22. Huttenlocher A., Werb Z., Tremble P., Huhtala P., Rosenberg L., Damsky C. H. Decorin regulates collagenase gene expression in fibroblasts adhering to vitronectin. Matrix Biol. 1996 Sep;15(4):239–250. doi: 10.1016/s0945-053x(96)90115-8. [DOI] [PubMed] [Google Scholar]
  23. Kasten F. H. Rat myocardial cells in vitro: mitosis and differentiated properties. In Vitro. 1972 Nov-Dec;8(3):128–150. doi: 10.1007/BF02619489. [DOI] [PubMed] [Google Scholar]
  24. Kingma I., Chea R., Davidoff A., Benediktsson H., Paul L. C. Glomerular capillary pressures in long-surviving rat renal allografts. Transplantation. 1993 Jul;56(1):53–60. doi: 10.1097/00007890-199307000-00009. [DOI] [PubMed] [Google Scholar]
  25. Ko Y. J., Sugar L., Zaltzman J., Paul L. C. alpha-smooth muscle actin and collagen deposition in dysfunctional renal transplants. Transplantation. 1997 Jan 15;63(1):156–158. doi: 10.1097/00007890-199701150-00028. [DOI] [PubMed] [Google Scholar]
  26. Lewis J. M., Cheresh D. A., Schwartz M. A. Protein kinase C regulates alpha v beta 5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation. J Cell Biol. 1996 Sep;134(5):1323–1332. doi: 10.1083/jcb.134.5.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lovett D. H., Haensch G. M., Goppelt M., Resch K., Gemsa D. Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol. 1987 Apr 15;138(8):2473–2480. [PubMed] [Google Scholar]
  28. Massy Z. A., Guijarro C., Kasiske B. L. Clinical predictors of chronic renal allograft rejection. Kidney Int Suppl. 1995 Dec;52:S85–S88. [PubMed] [Google Scholar]
  29. McLean I. W., Nakane P. K. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem. 1974 Dec;22(12):1077–1083. doi: 10.1177/22.12.1077. [DOI] [PubMed] [Google Scholar]
  30. Michielsen P., Vanrenterghem Y. Use of NSAIDs in kidney transplantation. Transplant Proc. 1993 Apr;25(2):2087–2088. [PubMed] [Google Scholar]
  31. Mihatsch M. J., Ryffel B., Gudat F. The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int Suppl. 1995 Dec;52:S63–S69. [PubMed] [Google Scholar]
  32. Paul L. C., Paradysz J. M., Milford E. L., Kunz H. W., Carpenter C. B. Expression of RT1.A and RT1.B/D antigens on endothelium of rat kidneys. Transplantation. 1982 Sep;34(3):121–128. doi: 10.1097/00007890-198209000-00002. [DOI] [PubMed] [Google Scholar]
  33. Paul L. C., Rennke H. G., Milford E. L., Carpenter C. B. Thy-1.1 in glomeruli of rat kidneys. Kidney Int. 1984 May;25(5):771–777. doi: 10.1038/ki.1984.89. [DOI] [PubMed] [Google Scholar]
  34. Paul L. C., Saito K., Davidoff A., Benediktsson H. Growth factor transcripts in rat renal transplants. Am J Kidney Dis. 1996 Sep;28(3):441–450. doi: 10.1016/s0272-6386(96)90504-1. [DOI] [PubMed] [Google Scholar]
  35. Pogány G., Hernandez D. J., Vogel K. G. The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate. Arch Biochem Biophys. 1994 Aug 15;313(1):102–111. doi: 10.1006/abbi.1994.1365. [DOI] [PubMed] [Google Scholar]
  36. Rosenblum N. D., Briscoe D. M., Karnovsky M. J., Olsen B. R. Alpha 1-VIII collagen is expressed in the rat glomerulus and in resident glomerular cells. Am J Physiol. 1993 Jun;264(6 Pt 2):F1003–F1010. doi: 10.1152/ajprenal.1993.264.6.F1003. [DOI] [PubMed] [Google Scholar]
  37. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  38. Russell P. S., Chase C. M., Winn H. J., Colvin R. B. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol. 1994 May 15;152(10):5135–5141. [PubMed] [Google Scholar]
  39. Schweitzer E. J., Matas A. J., Gillingham K. J., Payne W. D., Gores P. F., Dunn D. L., Sutherland D. E., Najarian J. S. Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg. 1991 Dec;214(6):679–688. doi: 10.1097/00000658-199112000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sharma K., Ziyadeh F. N. The emerging role of transforming growth factor-beta in kidney diseases. Am J Physiol. 1994 Jun;266(6 Pt 2):F829–F842. doi: 10.1152/ajprenal.1994.266.6.F829. [DOI] [PubMed] [Google Scholar]
  41. Shihab F. S., Tanner A. M., Shao Y., Weffer M. I. Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int. 1996 Dec;50(6):1904–1913. doi: 10.1038/ki.1996.512. [DOI] [PubMed] [Google Scholar]
  42. Shihab F. S., Yamamoto T., Nast C. C., Cohen A. H., Noble N. A., Gold L. I., Border W. A. Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol. 1995 Aug;6(2):286–294. doi: 10.1681/ASN.V62286. [DOI] [PubMed] [Google Scholar]
  43. Simonson M. S., Herman W. H. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src. J Biol Chem. 1993 May 5;268(13):9347–9357. [PubMed] [Google Scholar]
  44. Torbohm I., Schönermark M., Wingen A. M., Berger B., Rother K., Hänsch G. M. C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells. Kidney Int. 1990 Apr;37(4):1098–1104. doi: 10.1038/ki.1990.91. [DOI] [PubMed] [Google Scholar]
  45. Winnemöller M., Schmidt G., Kresse H. Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol. 1991 Feb;54(1):10–17. [PubMed] [Google Scholar]
  46. Xiao F., Chong A., Shen J., Yang J., Short J., Foster P., Sankary H., Jensik S., Mital D., McChesney L. Pharmacologically induced regression of chronic transplant rejection. Transplantation. 1995 Nov 27;60(10):1065–1072. doi: 10.1097/00007890-199511270-00001. [DOI] [PubMed] [Google Scholar]
  47. Yamaguchi Y., Mann D. M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990 Jul 19;346(6281):281–284. doi: 10.1038/346281a0. [DOI] [PubMed] [Google Scholar]
  48. Yaoita E., Oguri K., Okayama E., Kawasaki K., Kobayashi S., Kihara I., Okayama M. Isolation and characterization of proteoglycans synthesized by cultured mesangial cells. J Biol Chem. 1990 Jan 5;265(1):522–531. [PubMed] [Google Scholar]
  49. de Heer E., Davidoff A., van der Wal A., van Geest M., Paul L. C. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab Invest. 1994 Apr;70(4):494–502. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES